Proteoglycans in human malignant mesothelioma. Stimulation of their synthesis induced by epidermal, insulin and platelet-derived growth factors involves receptors with tyrosine kinase activity

Biochimie

Volumn 81, Issue 7, 1999, Pages 733-744

  Syrokou, Alexandra ^a   Tzanakakis, George N ^b   Hjerpe, Anders ^b   Karamanos, Nikos K ^a  

^a Section of Organic Chemistry   (Greece)

^b Pathol Infect Dis   (Sweden)

Author keywords

Glycosaminoglycans; Growth factors; Mesothelioma; Phosphokinase; Proteoglycans

Indexed keywords

CELL RECEPTOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GENISTEIN; HYALURONIC ACID; PERLECAN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; PROTEOCHONDROITIN SULFATE; PROTEOGLYCAN; PROTEOHEPARAN SULFATE; SOMATOMEDIN; SOMATOMEDIN C RECEPTOR; SYNDECAN; THROMBOMODULIN; VERSICAN;

ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MALIGNANT MESOTHELIOMA; PROTEOGLYCAN SYNTHESIS;

EID: 0032702067     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(99)80131-X     Document Type: Article

References (48)

1. Folkman J., Klagsbrun M., Sasse J., Wadzinski M., Ingber D., Vlodavsky I. A heparin-binding angiogenic protein-basic fibroblast growth factor- is stored within basement membrane. Am. J. Pathol. 130:1998;293-300.
2. Scott P.S., Dodd C.M., Tredget C.C., Ghahary A., Rahemtulla F. Immunohistochemical localization of the proteoglycans decorin, biglycan, and versican and transforming growth factor-β in human post-burn hepertrophic and mature scars. Histopathology. 26:1995;423-431.
3. Iozzo R.V. Perlecan: a gem of proteoglycan. Matrix Biol. 14:1994;203-208.
4. Fransson L.A., Carlstedt I., Coster L., Malmstrom A. The functions of heparan sulfate proteoglycans, in: Functions of Proteoglycans (Ciba Found. Symp. 124). 1986;125 John Wiley & Sons, Chichester.
5. Wight T.N., Kinsella M.G., Qwarnstrom E.E. The role of proteoglycans in cell adhesion, migration and proliferation. Curr. Opin. Cell Biol. 4:1992;793-801.
6. Ruoslahti E., Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell. 64:1991;867-869.
7. Elenius K., Jalkanen M. Function of the syndecans, a family of cell surface proteoglycans. J Cell Sci. 107:1994;2975-2982. Elenius.
8. Hardingham T.E., Fosang A.J. Proteoglycans: many forms and many functions. FASEB. 6:1992;861-870. Hardingham.
9. Asplund T., Heldin P. Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells. Cancer Res. 54:1994;4516-4523.
10. Asplund T., Versnel M.A., Laurent T.C., Heldin P. Human mesothelioma cells produce factors that stimulate the production of hyaluronan by mesothelial cells and fibroblasts. Cancer Res. 53:1993;388-392.
11. Tzanakakis G.N., Karamanos N.K., Klominek J., Hjerpe A. Glycosaminoglycans from two human malignant mesothelioma cell lines: determination, distribution, and effects of platelet-derived growth factor on their synthesis. Biochem. Cell Biol. 73:1995;59-66.
12. Tzanakakis G.N., Karamanos N.K., Hjerpe A. Effects on glycosaminoglycan synthesis in cultured human mesothelioma cells of transforming, epidermal, and fibroblast growth factors and their combinations with platelet-derived growth factor. Exp. Cell Res. 220:1995;130-137.
13. Tzanakakis G.N., Hjerpe A., Karamanos N.K. Proteoglycan synthesis induced by transforming and basic fibroblast growth factors in human malignant mesothelioma is mediated through specific receptors and the tyrosine kinase intracellular pathway. Biochimie. 79:1997;323-332.
14. Honda A., Noguchi N., Takehara H., Ohashi Y., Asuwa N., Mori Y. Co-operative enhancement of hyaluronic acid by combined use of IGF-I and EGF, and inhibition by tyrosine kinase inhibitor genistein, in cultured mesothelial cells from rabbit pericardial cavity. J. Cell Sci. 98:1991;91-98.
15. Syrokou A., Tzanakakis G., Tsegenidis T., Hjerpe A., Karamanos N.K. Effects of glycosaminoglycans in proliferation of epithelial and fibroblast human malignant mesothelioma cells. A structure-function relationship. Cell Prolif. 32:1998;. in press.
16. Batra R.K., Olsen J.C., Hoganson D.K., Caterson B., Boucher R.C. Retroviral gene transfer is inhibited by chondroitin sulfate proteoglycans / glycosaminoglycans in malignant pleural effusions. J. Biol. Chem. 272:1997;11736-11743.
17. Aaronson S.A. Growth factors and cancer. Science. 254:1991;1146-1153.
18. Cross M., Dexter T.M. Growth factors in development, transformation and tumorigenesis. Cell. 64:1991;271-280.
19. Bishop J.M. Cellular oncogenes and retroviruses. Annu. Rev. Biochem. 52:1983;301-354.
20. Peterson G. Evaluation of biochemical target of genistein in tumour cells. J. Nutr. 125:1995;784S-789S.
21. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor for tyrosine-specific protein kinases. J. Biol. Chem. 262:1987;5592-5595.
22. Tzanakakis G.N., Karamanos N.K., Syrokou A., Hjerpe A. Effect of insulin and epidermal growth factors on the synthesis of glycosaminoglycans/proteoglycans in cultured human malignant mesothelioma cells of different phenotypic morphology. APMIS. 104:1996;718-728.
23. Pardee A.B. G1 events and regulation of cell proliferation. Science. 246:1989;603-608.
24. Neal D.E., March C., Benett M.K., Abel P.D., Hall R.R., Sainsbury J.R.C. Epidermal growth factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet. I:1985;366-368.
25. Otani N., Tsukamoto T., Kumamoto Y., Miyao N. Study on in vitro invasive potential of renal cell carcinoma cell lines and effect of growth factors (EGF and TGF-β1) on their invasions. Jpn. J. Urol. 82:1991;613-619.
26. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 61:1990;203-212.
27. Peterson G., Barnes S. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem. Biophys. Res. Commun. 179:1991;661-667.
28. Watanabe T., Shiraishi T., Sasaki H., Oishi M. Inhibitors for protein-tyrosine kinases, ST638 and genistein: induce differentiation of mouse erythroleukemia cells in a synergistic manner. Exp. Cell Res. 183:1989;335-342.
29. 2 stimulated production in mesangial cells. Biochem. Res. Commun. 173:1990;718-724.
30. Trevillyan J.M., Lu Y., Atluru D., Phillips C.A., Byorndahl J.M. Differential inhibition of T cell receptor signal transduction and early activation events by a selective inhibitor of protein tyrosine kinase. J. Immunol. 145:1990;3223-3230.
31. Lories V., Cassiman J.J., Van denBerghe H., David G. Multiple dinstict membrane heparan sulfate proteoglycans in human lung fibroblasts. J. Biol. Chem. 264:1989;7009-7016.
32. Perides G., Rahemtulla F., Lane W.S., Asher R.A., Bigani A. Isolation of a large aggregating proteoglycan from human brain. J. Biol. Chem. 267:1992;23883-23887.
33. Klominek J., Robert K.H., Hjerpe A., Wikstrom B., Gahrton G. Serum-dependent growth patterns of two newly established human mesothelioma cell lines. Cancer Res. 49:1989;6118-6122.
34. Karamanos N.K. Proteoglycans: biological roles and strategies for isolation and determination of their glycan constituents. Kyriakidis D.A, Choli-Papadopoulou T, Kamp R.M. Proteome and protein analysis. 1999;Springer-Verlag, Inc.
35. Karamanos N.K., Aletras A.J., Antonopoulos C.A., Hjerpe A., Tsiganos C.P. Chondroitin proteoglycans from squid skin. Isolation characterization and immunological study. Eur. J. Biochem. 192:1990;33-38.
36. Karamanos N.K. Two squid skin proteoglycans each containing chondroitin sulphates with different sulphation patterns. Biochem. Cell Biol. 70:1992;629-635.
37. Scott J.E. Methods Biochemical Analysis. Click B. 1960;145 Interscience, New York. Vol. 8.
38. Yamagata T., Saito H., Habuchi O., Suzuki S. Purification and properties of bacterial chondroitinases and chondrosulfatases. J. Biol. Chem. 243:1968;1523-1535.
39. Karamanos N.K., Syrokou A., Vanky P., Nurminen M., Hjerpe A. Determination of twenty-four variously sulphated galactosaminoglycan- and hyaluronan-derived disaccharides by high-performance liquid chromatography. Anal. Biochem. 221:1994;189-199.
40. Karamanos N.K., Axelson S., Vanky P., Tzanakakis G., Hjerpe A. Determination of hyaluronan and galactosaminoglycan disaccharides by high-performance capillary electrophoresis at the attomole level. Application to analyses of tissue and cell culture proteoglycans. J. Chromatogr. A. 696:1995;295-305.
41. Hashimoto N., Morikava K., Kikuchi M., Yoshida K., Tokuyasu K. Purification and properties of a new keratan sulfate degrading enzyme. Seikagaku. 60:1988;935-938.
42. Linker A., Conrad H.E. Heparinase and heparitinase from Flavobacteria. Methods Enzymol. 28:1972;902-911.
43. Karamanos N.K., Vanky P., Tzanakakis G.N., Hjerpe A. High-performance capillary electrophoresis to characterise heparin and heparan sulfate disaccharides. Electrophoresis. 17:1996;391-395.
44. Karamanos N.K., Vanky P., Tzanakakis G., Tsegenidis T., Hjerpe A. Ion-pair high-performance liquid chromatography for determining disaccharide composition in heparin and heparan sulfate. J. Chromatogr. A. 765:1997;165-179.
45. Roskams T., Hoshage H., DeVos R., David G., Yap P., Desmet V. Heparan sulfate proteoglycan expression in normal human liver. Histopathology. 21:1995;950-958.
46. Oh E.S., Woods A., Couchman J.R. Syndecan-4 proteoglycan regulates the distribution and activity of protein kinase C. J. Biol. Chem. 272:1997;8133-8136.
47. Oh E.S., Woods A., Couchman J.R. Multimerization of the cytoplasmic domain of syndecan-4 is required for its ability to activate protein kinase C. J. Biol. Chem. 272:1997;11805-11811.
48. Kinnunen T., Kaksonen M., Saarinen J., Kalkkinen N., Peng H.B., Rauvala H. Cortactin-Src kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth. J. Biol. Chem. 273:1998;10702-10708.